August 27, 2019
August 27, 2019 —
For the first time in Southern California, surgeons at UC San Diego Health have transplanted the kidney of a deceased donor with HIV into a recipient with a pre-existing HIV infection. The procedure is part of an unprecedented multi-site national clinical trial.
August 11, 2022
August 11, 2022 —
In mouse studies, UC San Diego researchers find that excess alcohol consumption alters gut microbiome but latter is not directly or significantly linked to liver disease.
February 24, 2020
February 24, 2020 —
UC San Diego researchers suggest that prolonged exposure to a pair of antioxidant proteins may contribute to enlargement of the liver and fatty liver diseases.
May 12, 2016
May 12, 2016 —
…some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the…
January 11, 2016
January 11, 2016 —
UC San Diego Health and Sharp HealthCare have formed a joint program to enhance liver transplantation service¬¬s in San Diego by combining resources, collaborating on research and expanding specialized liver care. The alliance is expected to strengthen clinical services for patients with end-stage liver disease while reducing costs.
October 3, 2019
October 3, 2019 —
UC San Diego researchers investigated how a type of immune cell called a macrophage becomes specialized to the liver. Their study, published October 3, 2019 in Immunity, sets the stage for understanding how macrophage specialization gets disrupted by — or contributes to — liver disease.
October 10, 2013
October 10, 2013 —
…hepatocellular carcinoma tumors – the most common form of liver cancer. The researchers found ways to identify and isolate the HCC progenitor cells long before actual tumors were apparent.
January 5, 2012
January 5, 2012 —
A team led by Alan Hemming, MD, transplant surgeon at UC San Diego Health System, has successfully performed the west coast’s first ex-vivo liver resection, a radical procedure to completely remove and reconstruct a diseased liver and re-implant it without any tumors.
April 12, 2023
April 12, 2023 —
UC San Diego scientists find a protein associated with liver cancer may actually be the key to protecting against it. By blocking ferroptosis, a form of liver cell death, the protein prevents liver damage and its progression to cancer.
November 14, 2019
November 14, 2019 —
…classic bacterial infection: alcoholic liver disease. Bacteriophages are viruses that specifically destroy bacteria. In the early 20th century, researchers experimented with phages as a potential method for treating bacterial infections. But then antibiotics emerged and phages fell out of favor. With the rise of antibiotic-resistant infections, however, researchers have renewed…